Sientra Inc
F:S0Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cathay Pacific Airways Ltd
HKEX:293
|
HK |
|
ICRA Ltd
BSE:532835
|
IN |
|
H
|
Hybrid Financial Services Ltd
NSE:HYBRIDFIN
|
IN |
|
LG Innotek Co Ltd
KRX:011070
|
KR |
|
C
|
Compagnie Financiere Richemont SA
OTC:CFRHF
|
CH |
|
Futaba Corp
TSE:6986
|
JP |
|
Hangzhou Freely Communication Co Ltd
SSE:603602
|
CN |
|
E
|
Etga Group Ltd
TASE:ETGA
|
IL |
Sientra Inc
Research & Development
Sientra Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sientra Inc
F:S0Z
|
Research & Development
-$11.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$62.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Research & Development
-$87.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-19%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$369.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-20%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$177.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-29%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$97.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
Sientra Inc
Glance View
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.
See Also
What is Sientra Inc's Research & Development?
Research & Development
-11.8m
USD
Based on the financial report for Sep 30, 2023, Sientra Inc's Research & Development amounts to -11.8m USD.
What is Sientra Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-3%
Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Sientra Inc have been -5% over the past three years , -3% over the past five years .